Cinquegrani, Gloria
Spigoni, Valentina
Fantuzzi, Federica
Bonadonna, Riccardo C.
Dei Cas, Alessandra
Funding for this research was provided by:
Italian Diabete Ricerca Foundation and Eli Lilly Italy
FIL funds from University of Parma
Article History
Received: 24 August 2021
Accepted: 31 January 2022
First Online: 17 February 2022
Declarations
:
: This study protocol was approved by the Regional Institutional Review Board (Comitato Etico Area Vasta Emilia Nord Prot. 39779 and 20731) and carried out in accordance with the Declaration of Helsinki. No informed consent was required, as blood donor material was completely anonymized.
: Not applicable.
: RCB is a member of the following board/advisory panel: MSD, Eli Lilly Ltd, Amgen, Sanofi and invited speaker for Sanofi, MSD, Eli Lilly Ltd, Astra Zeneca, Janssen. ADC is an invited speaker for MSD, Astra Zeneca, Sanofi, Eli Lilly Ltd, DOC generici, Servier. All other authors declare that they have no competing interests.